123 related articles for article (PubMed ID: 2232364)
1. Pulmonary drug-metabolizing enzyme in alveolar macrophages in relation to cigarette smoking.
Abe S; Makimura S; Ogura S; Nakajima I; Kawakami Y
Jpn J Med; 1990; 29(2):164-7. PubMed ID: 2232364
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon hydroxylase activity in pulmonary alveolar macrophages and lymphocytes from lung cancer and noncancer patients: a correlation with family histories of cancer.
McLemore TL; Martin RR; Springer RR; Wray N; Cantrell ET; Busbee DL
Biochem Genet; 1979 Oct; 17(9-10):795-806. PubMed ID: 540021
[TBL] [Abstract][Full Text] [Related]
3. In vitro induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by benzanthracene.
Mclemore TL; Martin RR
Cancer Lett; 1977 May; 2(6):327-33. PubMed ID: 861927
[TBL] [Abstract][Full Text] [Related]
4. Analysis of aryl hydrocarbon hydroxylase activity in human lung tissue, pulmonary macrophages, and blood lymphocytes.
McLemore TL; Martin RR; Pickard LR; Springer RR; Wray NP; Toppell KL; Mattox KL; Guinn GA; Cantrell ET; Busbee DL
Cancer; 1978 Jun; 41(6):2292-300. PubMed ID: 657093
[No Abstract] [Full Text] [Related]
5. Reassessment of the relationship between aryl hydrocarbon hydroxylase and lung cancer.
McLemore TL; Martin RR; Wray NP; Cantrell ET; Busbee DL
Cancer; 1981 Sep; 48(6):1438-43. PubMed ID: 7272966
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls.
Kärki NT; Pokela R; Nuutinen L; Pelkonen O
Int J Cancer; 1987 May; 39(5):565-70. PubMed ID: 3570549
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer.
Yoshikawa M; Arashidani K; Kawamoto T; Kodama Y
Environ Res; 1994 Apr; 65(1):1-11. PubMed ID: 8162876
[TBL] [Abstract][Full Text] [Related]
8. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.
Kiyohara C; Nakanishi Y; Inutsuka S; Takayama K; Hara N; Motohiro A; Tanaka K; Kono S; Hirohata T
Pharmacogenetics; 1998 Aug; 8(4):315-23. PubMed ID: 9731718
[TBL] [Abstract][Full Text] [Related]
9. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages and peripheral lymphocytes by cigarette tars.
McLemore TL; Warr GA; Martin RR
Cancer Lett; 1977 Jan; 2(3):161-7. PubMed ID: 837362
[TBL] [Abstract][Full Text] [Related]
10. Comparison of aryl hydrocarbon hydroxylase induction in cultured blood lymphocytes and pulmonary macrophages.
McLemore TL; Martin RR; Toppell KL; Busbee DL; Cantrell ET
J Clin Invest; 1977 Nov; 60(5):1017-24. PubMed ID: 908748
[TBL] [Abstract][Full Text] [Related]
11. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
Kiyohara C; Hirohata T
J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer.
Ward E; Paigen B; Steenland K; Vincent R; Minowada J; Gurtoo HL; Sartori P; Havens MB
Int J Cancer; 1978 Oct; 22(4):384-9. PubMed ID: 212378
[TBL] [Abstract][Full Text] [Related]
13. [A role of aryl hydrocarbon hydroxylase inducibility in susceptibility to lung carcinogenesis].
Kiyohara C; Hirohata T
Nihon Eiseigaku Zasshi; 1994 Feb; 48(6):1027-36. PubMed ID: 8126925
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
[TBL] [Abstract][Full Text] [Related]
15. [The role of aromatic hydrocarbon hydroxylase in the pathogenesis of lung cancer].
Pilarska-Machowicz A
Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):303-7. PubMed ID: 2235714
[TBL] [Abstract][Full Text] [Related]
16. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C
Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722
[TBL] [Abstract][Full Text] [Related]
17. [Role of aryl hydrocarbon hydroxylase in developing laryngeal cancer among smokers].
Wu Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(6):325-7, 381. PubMed ID: 1811685
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between aryl hydrocarbon hydroxylase activity in cultured pulmonary macrophages and blood lymphocytes from lung cancer patients.
McLemore TL; Martin RR; Wray NP; Cantrell ET; Busbee DL
Cancer Res; 1978 Nov; 38(11 Pt 1):3805-11. PubMed ID: 698938
[No Abstract] [Full Text] [Related]
19. Correlation between lung cancer prevalence and activities of aryl hydrocarbon hydroxylase and glutathione S-transferase in human lung tissues.
Liu L; Wang LH
Biomed Environ Sci; 1988 Oct; 1(3):277-82. PubMed ID: 3270515
[TBL] [Abstract][Full Text] [Related]
20. Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes.
Suolinna EM; Vänttinen E; Aitio A
Toxicology; 1982; 24(1):73-84. PubMed ID: 7135405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
